PD-1 Inhibition in Advanced Myeloproliferative Neoplasms
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Polycythemia Vera
Related studies linked through entity extraction aliases.
The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure
- Status
- COMPLETED
- Phase
- N/A
Myeloproliferative Neoplastic Diseases Observatory From Brest
- Status
- RECRUITING
- Phase
- N/A
Drug Observance and Side Effects of Cytoreductive Drugs in PV and ET Patients
- Status
- COMPLETED
- Phase
- N/A
Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms
- Status
- COMPLETED
- Phase
- N/A
Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features
- Status
- UNKNOWN
- Phase
- N/A
Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Myeloproliferative Neoplasms (MPNs) Patient Registry
- Status
- RECRUITING
- Phase
- N/A
Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders
- Status
- WITHDRAWN
- Phase
- N/A
Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients
- Status
- COMPLETED
- Phase
- PHASE3
TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea
- Status
- COMPLETED
- Phase
- PHASE1
Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia
- Status
- COMPLETED
- Phase
- PHASE1
CINC424A2X01B Rollover Protocol
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation
- Status
- COMPLETED
- Phase
- PHASE2
Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.
- Status
- COMPLETED
- Phase
- PHASE3
AOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.
- Status
- COMPLETED
- Phase
- PHASE3
Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia
- Status
- COMPLETED
- Phase
- PHASE2